Vahid Mohsenin, MD
Cards
About
Research
Publications
2023
Polysomnography
Jafari B, Mohsenin V. Polysomnography. 2023, 374-387. DOI: 10.1016/b978-0-12-822963-7.00174-2.Peer-Reviewed Original ResearchMovement disordersREM sleep behavior disorderSleep behavior disorderSleep-disordered breathingArterial oxygen saturationSleep stagesREM sleep stagesLimb electromyogramsCardiorespiratory functionRespiratory effortSleep architectureArousal disorderOxygen saturationChin electromyogramDiagnostic utilityOrgan functionPolysomnographyBehavior disorderOral airflowSleepDisordersEye movementsStage WElectromyogramBreathing
2022
Obstructive Sleep Apnea and Polycystic Ovary Syndrome
Chu Y, Hilbert J, Mohsenin V. Obstructive Sleep Apnea and Polycystic Ovary Syndrome. 2022, 393-409. DOI: 10.1007/978-3-030-92589-5_20.Peer-Reviewed Original ResearchPolycystic ovary syndromeObstructive sleep apneaCardiovascular outcomesOvary syndromeSleep apneaPathogenesis of OSAPrevalence of OSARepetitive upper airway obstructionsUntreated sleep-disordered breathingExcess of androgensUpper airway obstructionImproved cardiovascular outcomesSleep-disordered breathingSleep breathing disordersWeight-matched controlsImproved sleep qualityRates of obesityAirway obstructionNorepinephrine levelsCentral adiposityAtypical symptomsInsulin resistanceTreatment optionsSex hormonesTreatment benefit
2021
Pulmonary Hypertension in Obstructive Sleep Apnea
Mohsenin V. Pulmonary Hypertension in Obstructive Sleep Apnea. 2021, 69-76. DOI: 10.1007/978-3-030-57942-5_6.Peer-Reviewed Original ResearchMean pulmonary artery pressurePulmonary hypertensionChronic obstructive pulmonary diseaseMild pulmonary arterial hypertensionPulmonary artery pressurePulmonary arterial hypertensionThird of patientsChronic lung diseaseObstructive pulmonary diseaseObstructive sleep apneaTreatment of OSADaytime hypoxemiaArterial hypertensionArtery pressureObesity hypoventilationHeart failurePulmonary diseaseSleep apneaLung diseaseHypertensionOSAPatientsDiseaseCurrent definitionHypoxemia
2020
Obstructive Sleep Apnea Increases the Risk of Pulmonary Hypertension Independent of Relevant Risk Factors
Shojaee A, Mohsenin V. Obstructive Sleep Apnea Increases the Risk of Pulmonary Hypertension Independent of Relevant Risk Factors. 2020, a6252-a6252. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6252.Peer-Reviewed Original Research
2018
Treating Sleep-Related Breathing Disorders
Won C, Mohsenin V, Kryger M. Treating Sleep-Related Breathing Disorders. 2018, 105-123. DOI: 10.1007/978-1-4939-8607-1_9.Peer-Reviewed Original ResearchPositive airway pressure therapySignificant symptomatic benefitAirway pressure therapySleep-disordered breathingMental health outcomesNeuropsychomotor functionsPAP therapyMainstay treatmentSymptomatic benefitPAP adherenceBreathing disordersPressure therapySide effectsHealth outcomesPatientsTherapyEffective alternativeAdherenceRobust evidenceTolerabilityBreathingSleep
2017
Chapter 122 Sleep and Breathing at High Altitude
Mohsenin V, Javaheri S, Dempsey J. Chapter 122 Sleep and Breathing at High Altitude. 2017, 1211-1221.e4. DOI: 10.1016/b978-0-323-24288-2.00122-7.Peer-Reviewed Original Research
2016
Chitinase-3-like protein-1 (YKL-40) as a marker of endothelial dysfunction in obstructive sleep apnea
Jafari B, Mohsenin V. Chitinase-3-like protein-1 (YKL-40) as a marker of endothelial dysfunction in obstructive sleep apnea. Sleep Medicine 2016, 25: 87-92. PMID: 27823723, DOI: 10.1016/j.sleep.2016.08.001.Peer-Reviewed Original ResearchConceptsHypertensive OSAObstructive sleep apneaFlow-mediated vasodilationEndothelial dysfunctionYKL-40Sleep apneaEndothelial-dependent vasodilatory capacityNormotensive OSAChitinase-3-like protein 1Sleep-disordered breathingCharacteristic curve analysisChitinase-3-like proteinHypertension independentVasodilatory capacityCardiovascular morbidityEndothelial functionHypertension statusRisk factorsPrevalent disorderHypertensionNegative correlationDysfunctionPotential biomarkersSignificant negative correlationCurve analysisThe emerging role of microRNAs in hypoxia-induced pulmonary hypertension
Mohsenin V. The emerging role of microRNAs in hypoxia-induced pulmonary hypertension. Sleep And Breathing 2016, 20: 1059-1067. PMID: 27154628, DOI: 10.1007/s11325-016-1351-y.Peer-Reviewed Original ResearchConceptsPulmonary arterial hypertensionHypoxia-induced pulmonary hypertensionPulmonary hypertensionArterial hypertensionHeart failureRole of microRNAsMechanism of PHPulmonary arterial blood pressurePulmonary arterial smooth muscle cellsDevelopment of PHIdiopathic pulmonary arterial hypertensionChronic obstructive lung diseasePathogenesis of PHArterial smooth muscle cellsRight heart failureRight ventricular dysfunctionPoor prognostic signArterial blood pressureCongestive heart failureObstructive lung diseaseSleep-disordered breathingSetting of hypoxiaAberrant vascular remodelingQuality of lifeSmooth muscle cellsModafinil and sleep architecture in an inpatient–outpatient treatment study of cocaine dependence
Morgan PT, Angarita GA, Canavan S, Pittman B, Oberleitner L, Malison RT, Mohsenin V, Hodges S, Easton C, McKee S, Bessette A, Forselius E. Modafinil and sleep architecture in an inpatient–outpatient treatment study of cocaine dependence. Drug And Alcohol Dependence 2016, 160: 49-56. PMID: 26777774, PMCID: PMC4767553, DOI: 10.1016/j.drugalcdep.2015.12.004.Peer-Reviewed Original ResearchConceptsUrine toxicology screenModafinil treatmentSlow-wave sleepClinical outcomesOutpatient treatmentToxicology screenUrine screensInpatient settingInpatient treatmentSleep timeCocaine dependencePrimary clinical outcomeWeekly cognitive behavioral therapyCocaine usersImproved clinical outcomesPolysomnographic sleep recordingsChronic cocaine useChronic cocaine usersHigh rateCognitive behavioral therapyCocaine-dependent participantsSleep architectureOutpatient phaseEffective treatmentDays abstinent
2015
Feasibility and Efficacy of a Self-Management Intervention for Insomnia in Stable Heart Failure.
Redeker NS, Jeon S, Andrews L, Cline J, Jacoby D, Mohsenin V. Feasibility and Efficacy of a Self-Management Intervention for Insomnia in Stable Heart Failure. Journal Of Clinical Sleep Medicine 2015, 11: 1109-19. PMID: 25979100, PMCID: PMC4582052, DOI: 10.5664/jcsm.5082.Peer-Reviewed Original ResearchConceptsStable heart failureHeart failureSelf-management interventionsChronic insomniaEffect of comorbidityShort-term efficacyInsomnia Severity IndexTreatment of insomniaMeasures of fatigueEffects of CBTAttention control conditionDaytime symptomsPoor functionPreliminary efficacyStable class IWrist actigraphyInsomniaPatientsClass ISeverity IndexEfficacyCBTFunctional performanceTrialsControl condition
Links & Media
News
- September 30, 2021
Sleep Medicine Expert Mohsenin Retires From Clinical Work
- June 14, 2019
Over 200 Yale Medicine Physicians Make 2019 ‘Best Doctors’ List
- January 25, 2016
Improved sleep can help addicts recover
- June 02, 2014
Sleep apnea and vascular problems: An ancient molecule underlies the mechanism